Qilu Institute of Pharmaceutical Research

Qilu Pharmaceutical is a leading vertically integrated Chinese pharmaceutical company headquartered in Jinan, Shandong. The company specializes in the development, manufacturing, and marketing of generic and innovative drugs across various therapeutic areas, including oncology, cardiovascular, and anti-infectives. Its R&D arm, the Qilu Institute of Pharmaceutical Research, operates multiple centers globally, focusing on high-end generics, biosimilars, and novel biologics such as ADCs and monoclonal antibodies. Qilu is one of the largest pharmaceutical exporters in China, with products sold in over 90 countries. The company maintains a robust pipeline of innovative biologics and small molecules, supported by extensive manufacturing capabilities and a global R&D presence in the United States and China.